James Molloy
Stock Analyst at Alliance Global Partners
(0.42)
# 3,994
Out of 4,843 analysts
33
Total ratings
20.59%
Success rate
-43.2%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGC IGC Pharma | Reiterates: Buy | $3.5 | $0.31 | +1,013.23% | 2 | Mar 6, 2025 | |
| INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $0.48 | +1,688.72% | 1 | Jan 13, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $15.89 | +120.26% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $15 | $1.02 | +1,370.59% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $7.38 | +171.00% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $490 | $5.12 | +9,470.31% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $39.78 | +2,665.21% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.64 | +173.01% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $2.88 | +247.83% | 1 | Jul 17, 2024 | |
| CHRO Channel Therapeutics | Initiates: Buy | n/a | $0.93 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $0.94 | +1,389.36% | 2 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.15 | +2,508.70% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.54 | +387.01% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $6.24 | +220.77% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.71 | +367.84% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $2.71 | +158.30% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.33 | +5,915.04% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.97 | +1,549.14% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.39 | +3,489.74% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.49 | +502.41% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,400 | $8.53 | +98,375.97% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $2.11 | +7,009.00% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $938 | $1.18 | +79,349.15% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $3.58 | +598.32% | 1 | Oct 4, 2021 |
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.31
Upside: +1,013.23%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $0.48
Upside: +1,688.72%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $15.89
Upside: +120.26%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $1.02
Upside: +1,370.59%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $7.38
Upside: +171.00%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $5.12
Upside: +9,470.31%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $39.78
Upside: +2,665.21%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.64
Upside: +173.01%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $2.88
Upside: +247.83%
Channel Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $0.93
Upside: -
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $0.94
Upside: +1,389.36%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.15
Upside: +2,508.70%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.54
Upside: +387.01%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $6.24
Upside: +220.77%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.71
Upside: +367.84%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $2.71
Upside: +158.30%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $1.33
Upside: +5,915.04%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $0.97
Upside: +1,549.14%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $0.39
Upside: +3,489.74%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $2.49
Upside: +502.41%
Sep 7, 2022
Initiates: Buy
Price Target: $8,400
Current: $8.53
Upside: +98,375.97%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $2.11
Upside: +7,009.00%
Jun 1, 2022
Initiates: Buy
Price Target: $938
Current: $1.18
Upside: +79,349.15%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $3.58
Upside: +598.32%